Evaluation of new agglutination test for identification of oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus.
A new agglutination test (Monostaph +; Bionor, Skien, Norway) has been developed. This new agglutination test has been compared with two other agglutination tests for the identification of 128 isolates of Staphylococcus aureus and 82 coagulase-negative staphylococci. The sensitivities of both Monostaph + and Pastorex Staph-Plus were excellent (98.7 and 97.4%, respectively) in detection of oxacillin-resistant Staphylococcus aureus. The specificity was 96.4% (two Staphylococcus epidermidis isolates and one Staphylococcus hominis isolate were false positive).
Tveten
Y
Y
Department of Microbiology, Telemark Biomedical Centre, Skien, Norway.
D000372:Agglutination Tests / Q000379:methods* / Q000706:statistics & numerical data; D003030:Coagulase / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005189:False Positive Reactions; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000706:statistics & numerical data; D010068:Oxacillin / Q000494:pharmacology*; D010403:Penicillin Resistance; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012680:Sensitivity and Specificity; D012703:Serotyping; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D013212:Staphylococcus epidermidis / Q000187:drug effects / Q000302:isolation & purification
D003030:Coagulase; D011135:Polysaccharides, Bacterial; D010068:Oxacillin